Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial

Circulation: Heart Failure

Volumn 5, Issue 2, 2012, Pages 217-225

  Rector, Thomas S ^a   Carson, Peter E ^b   Anand, Inder S ^a   McMurray, John J ^c   Zile, Michael R ^d   McKelvie, Robert S ^e   Komajda, Michel ^e,f   Kuskowski, Michael ^a   Massie, Barry M ^g  

^a UNIVERSITY OF MINNESOTA   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ARBs; Diastolic heart failure; Quality of life

Indexed keywords

IRBESARTAN;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSPNEA; FATIGUE; FEMALE; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINNESOTA LIVING WITH HEART FAILURE QUESTIO; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; VALIDITY;

AGED; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BIPHENYL COMPOUNDS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; MALE; MINNESOTA; QUESTIONNAIRES; STROKE VOLUME; SURVIVAL RATE; SYSTOLE; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84860802725     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.111.964221     Document Type: Article

References (24)

1. Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure, part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Failure. 1987;Oct/Nov:198-209.
2. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124:1017-1025.
3. Rector TS. A conceptual model of quality of life in relation to heart failure. J Card Fail. 2005;11:173-176. (Pubitemid 40462418)
4. Lewis EF, Lamas GA, O'Meara E, Granger CB, Dunlap ME, McKelvie RS, Probstfield JL, Young JB, Michelson EL, Halling K, Carlsson J, Olofsson, McMurray JJV, Yusuf S, Swedberg K, Pfeffer MA; for the CHARM investigators. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur J Heart Fail. 2007;9:83-91. (Pubitemid 46074490)
5. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, Brosnihan B, Morgan TM, Stewart KP. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA. 2002;288:2144-2150. (Pubitemid 35265382)
6. Badano LP, Albanese MC, Biaggio PD, Rozbowsky P, Miani D, Fresco C, Fioretti PM. Prevalence, clinical characteristics, quality of life and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction. J Am Soc Echocardiogr. 2004;17:253-261. (Pubitemid 38879257)
7. McMurray JJV, Carson PE, Komajda M, McKelvie R, Zile MR, Ptaszynska A, Staiger C, Donovan JM, Massie BM. Heart failure with preserved ejection fraction: clinical characteristics of 4,133 patients enrolled in the I PRESERVE trial. Eur J Heart Failure. 2008;10: 149-156. (Pubitemid 351227428)
8. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie, Zile M, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A; for the I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359:2456-2467.
9. Carson P, Massie BM, McKelvie R, McMurray J, Komajda M, Zile M, Ptaszynska A, Frangin G; for the I-PRESERVE investigators. The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: rationale and design. J Card Fail. 2005;11:576-585. (Pubitemid 41463727)
10. Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE; for the I-PRESERVE Investigators. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011;124:2491-2501.
11. Heise DR. Separating reliability and stability in test-retest correlation. Am Sociological Rev. 1969;34:93-101.
12. Rector TS, Anand IS, Cohn JN. Relationships between clinical assessments and patients' perceptions of the effects of heart failure on their quality of life. J Card Fail. 2006;12:87-92. (Pubitemid 43340148)
13. Carson P, Tam W, Ghall JK, Archambault WT, Taylor A, Cohn JN, Braman VM, Worcel M, Anand IS. Relationship of quality of life scores with baseline characteristics and outcomes in the African-American Heart Failure Trial. J Cardiac Fail. 2009;15:835-842.
14. Hoekstra T, Lesman-Leegte I, van Veldhuisen DJ, Sanderman R, Jaarsma T. Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction. Eur J Heart Fail. 2011;13:1013-1018.
15. Yip GWK, Wang M, Wang T, Chan S, Fung JWH, Yeung L, Yip T, Lau S-T, Lau C-P, Tang M-O, Yu C-M, Sanderson JE. The Hong Kong diastolic heart failure study: a randomized controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart. 2008;94:573-580. (Pubitemid 351580128)
16. Gorkin L, Norvell NK, Rosen RC, Charles E, Schumaker SA, McIntyre KM, Capone RJ, Kostis J, Niaura R, Woods P, Hosking J, Garces C, Handberg E, Ahern DK, Follick MJ; for the SOLVD Investigators. Assessment of quality of life as observed from the baseline data of the Studies of Left Ventricular Dysfunction (SOLVD) trial quality-of-life substudy. Am J Cardiol. 1993;71:1069-1073. (Pubitemid 23126816)
17. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol. 1993;71:1106-1107. (Pubitemid 23126823)
18. Bennett SJ, Oldridge NB, Eckert GJ, Embree JL, Browning S, Hou N, Deer M, Murray MD. Discriminant properties of commonly used quality of life measures in heart failure. Qual Life Res. 2002;11:349-359. (Pubitemid 34596857)
19. Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusterman N for the MOCHA Investigators. Carvedilol produces doserelated improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation. 1996;94:2807-2816. (Pubitemid 26411745)
20. Cohn JN, Fowler MB, Bristow MR, Colucci WS, Gilbert EM, Kinhal V, Krueger SK, Lejemtel T, Narahara KA, Packer M, Young ST, Holcslaw TL, Lukas MA for the U.S. Carvedilol Heart Failure Study Group. Safety and efficacy of cardvedilol in severe heart failure. J Card Fail. 1997;3: 173-179.
21. Udelson JE, McGrew FA, Flores E, Ibrahim H, Katz S, Koshkarian G, O'Brien T, Kronenberg MW, Zimmer C, Orlandi C, Konstam MA. Multicenter, randomized double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction. J Am Coll Cardiol. 2007;49: 2151-2159. (Pubitemid 46817812)
22. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon S, Suter T, Osterhues HH, Schieber MM, Hilti P, Schinder R, La Rocca HPB; for the TIME-CHF Investigators. BNP-guided versus symptom-guided heart failure therapy. JAMA. 2009;301:383-392.
23. Kasper EK, Gerstenblith G, Hefter G, Van Anden E, Brinker JA, Thiemann DR, Terrin M, Forman S, Gottlieb SH. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol. 2002;39:471-480. (Pubitemid 34117505)
24. Konstam V, Gregory D, Chen J, Weintraub A, Patel A, Levine D, Venesy D, Perry K, Delano C, Konstam MA. Health-related quality of life in a multicenter randomized controlled comparison of telephone disease management and automated home monitoring in patients recently hospitalized with heart failure: SPAN-CHF II Trial. J Card Fail. 2011;17:151-157.